← Back to Search

Home Urodynamics Testing for Neurogenic Bladder

N/A
Waitlist Available
Led By Christopher S Cooper, MD
Research Sponsored by University of Iowa
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients seen in the University of Iowa Pediatric Urology Clinic with neurogenic bladder managed with clean intermittent catheterization
Timeline
Screening 3 weeks
Treatment Varies
Follow Up two weeks
Awards & highlights

Study Summary

This trial will study a new device for measuring pressure in the bladder for people who have a neurogenic bladder and use a urinary catheter. The device is easy to use and can be done at home.

Who is the study for?
This trial is for patients with neurogenic bladder who manage their condition using clean intermittent catheterization and are seen at the University of Iowa Pediatric Urology Clinic. They should have had a recent urodynamic study and no changes in management. Those without an iOS-compatible phone cannot participate.Check my eligibility
What is being tested?
The trial is testing a new device called 'cystoelastometer' designed for home use to monitor bladder pressure, which could be an alternative to clinical urodynamics tests. The focus is on assessing how well patients and caregivers can use this device at home.See study design
What are the potential side effects?
Since the cystoelastometer is a monitoring device rather than a medication, traditional side effects like those from drugs are not expected. However, there may be discomfort or issues related to its use with urinary catheters.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have a neurogenic bladder and use catheters for management, seen at the University of Iowa.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~two weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and two weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Home use of bladder pressure and volume monitoring device- Cystoelastometer

Trial Design

1Treatment groups
Experimental Treatment
Group I: Neurogenic Bladder PatientExperimental Treatment1 Intervention
Patients with neurogenic bladder

Find a Location

Who is running the clinical trial?

University of IowaLead Sponsor
446 Previous Clinical Trials
879,472 Total Patients Enrolled
Christopher S Cooper, MDPrincipal InvestigatorUniversity of Iowa
1 Previous Clinical Trials
50 Total Patients Enrolled

Media Library

Cystoelastometer - Urodynamics Testing 2023 Treatment Timeline for Medical Study. Trial Name: NCT05232253 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the maximum capacity of participants for this research endeavor?

"Affirmative. According to clinicaltrials.gov, this research is actively recruiting participants; the study was initially posted on February 18th 2021 and edited lastly on January 29th 2022. 30 volunteers need to be enrolled from a single medical centre."

Answered by AI

Am I eligible to partake in this experiment?

"To qualify for inclusion in this medical trial, patients must have urinary bladder and neurogenic conditions with an age range between 6 months old to 99 years. 30 participants will be accepted into the study."

Answered by AI

Does this medical experiment allow for geriatric participation?

"This medical trial is recruiting patients who are at least 6 months old and below the age of 99."

Answered by AI

Is there availability for participants to join this experiment?

"According to clinicaltrials.gov, this investigation is currently looking for participants. It was first published on February 18th 2021 and underwent its latest update January 29th 2022."

Answered by AI
~10 spots leftby Feb 2026